Could a bone marrow shot stop arthritis after ACL surgery?
NCT ID NCT06311513
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a concentrated bone marrow injection (cBMA) given during repeat ACL surgery can reduce knee pain and signs of arthritis. About 40 adults aged 18-55 who need a second ACL repair will receive either cBMA plus surgery or surgery alone. Researchers will track pain, inflammation, and knee function for two years to see if the treatment helps control post-traumatic osteoarthritis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACL INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Orthopaedics & Spine Center
RECRUITINGAtlanta, Georgia, 30097, United States
-
Hospital for Special Surgery
RECRUITINGNew York, New York, 10021, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 3D-Printed gadget speed up knee recovery?
- Saving the ligament: a trial tests whether repairing a torn ACL beats replacing it
- Which workout rebuilds a repaired knee best? a head-to-head trial of movement vs stability training
- Stem cell byproduct may boost ACL graft healing — trial puts it to the test
- Which tendon graft helps female athletes recover best after ACL surgery?
- Nerve block showdown: which technique eases ACL surgery pain best?